Table 1 Demographic, clinical and laboratory parameters of patients who received an endoscopic decompression tube
Median/number | IQR (25–75) | |
|---|---|---|
Age (years) | 54 | 39–68 |
Gender | ||
Female | 19 | |
Male | 31 | |
Body mass index (kg/m2) | 24.5 | 20.4–29.2 |
Follow up (days) | 20 | 11–42 |
Placement of tube after first diagnosis (days) | 1 | 0–6 |
Length of hospital stay (days) | 37 | 19–68 |
Treatment on ICU (days) | 14 | 0–37 |
Mechanical ventilation (days) | 4 | 0–25 |
Renal replacement therapy | ||
No | 41 | |
Yes | 8 | |
Opiods | ||
No | 30 | |
Yes | 19 | |
Cause of intestinal obstruction | ||
Trauma | 1 | |
Infection | 9 | |
Neurological | 4 | |
Operation | 7 | |
Tumor | 11 | |
Others | 18 | |
Laboratory parameters at first diagnosis | ||
Leukocytes (n/μL) | 6715 | 4800–12,900 |
Platelets (Thsd/μL) | 182 | 88–271 |
Hemoglobin (g/dL) | 9,9 | 8.6–11.5 |
INR (Ratio) | 1.15 | 1.04–1.34 |
CRP (mg/L) | 107 | 29–248 |
PCT (μg/L) | 1 | 0–3.3 |
Creatinine (μmol/L) | 91 | 61–169 |
Lactate (mmol/L) | 1,1 | 0.8–2.2 |
Bilirubin (μmol/L) | 17 | 19,906 |
Lactate dehydrogenase (U/L) | 262 | 172–394 |
Alkaline phospahatse (U/L) | 95 | 78–256 |
Gamma-glutamyl transferase (U/L) | 63 | 34–401 |
Alanine aminotransferase (U/L) | 24 | 13–65 |